CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Net sales	$ 167,366	$ 139,025	$ 299,079	$ 269,513
Cost of goods sold	101,847	83,929	184,553	163,219
Gross profit	65,519	55,096	114,526	106,294
Selling expenses	49,328	39,097	88,243	77,535
General and administrative expenses	13,914	13,793	25,241	22,729
Restructuring and other transition expenses	139	3,965	259	6,995
Net gain from sale of Torrance Facility	0	(37,449)	0	(37,449)
Net gains from sale of spice assets	(395)	(334)	(545)	(492)
Net losses (gains) from sales of other assets	91	114	144	(1,439)
Operating expenses	63,077	19,186	113,342	67,879
Income from operations	2,442	35,910	1,184	38,415
Other (expense) income:
Dividend income	6	270	11	535
Interest income	1	159	2	288
Interest expense	(861)	(524)	(1,384)	(913)
Other, net	554	(2,323)	641	(2,132)
Total other expense	(300)	(2,418)	(730)	(2,222)
Income before taxes	2,142	33,492	454	36,193
Income tax expense	20,910	13,416	20,200	14,499
Net (loss) income	(18,768)	20,076	(19,746)	21,694
Less: Cumulative preferred dividends, undeclared and unpaid	129	0	129	0
Net (loss) income available to common stockholders	$ (18,897)	$ 20,076	$ (19,875)	$ 21,694
Net income (loss) per common share - basic (in US$ per share)	$ (1.13)	$ 1.21	$ (1.19)	$ 1.31
Net income (loss) per common share - diluted (in US$ per share)	$ (1.13)	$ 1.20	$ (1.19)	$ 1.30
Weighted average common shares outstanding - basic (in shares)	16,723,498	16,584,106	16,711,660	16,573,545
Weighted average common shares outstanding—diluted (in shares)	16,723,498	16,707,003	16,711,660	16,695,687